Key result
PTCA linked to significant epicardial fat reduction at three years in ACS vs non-revascularization.
Why the study?
The study aimed to assess the relationship between echocardiographic epicardial adipose tissue (EAT) thickness and CAD severity, investigate its association with coronary revascularization, and explore post-angioplasty changes in EAT depots.
Does percutaneous transluminal coronary angioplasty reduce epicardial adipose tissue thickness in patients with acute coronary syndrome?
Observational (n=150)
Single-blind
No
Does percutaneous transluminal coronary angioplasty reduce epicardial adipose tissue thickness in patients with acute coronary syndrome?
p-value: p=<0.001
Epicardial fat thickness correlates with coronary artery disease severity and significantly decreases following percutaneous coronary revascularization, suggesting its utility as a dynamic marker of cardiovascular risk.
May support EAT thickness as a dynamic marker after PTCA in ACS; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: this study aimed to assess the complex relationship between EAT thickness, as measured with echocardiography, and the severity of coronary artery disease (CAD). We investigated whether individuals with higher EAT thickness underwent coronary revascularization. Subsequently, we conducted a three-year follow-up to explore any potential modifications in EAT depots post-angioplasty. METHODS: we conducted a prospective and retrospective cross-sectional observational study involving 150 patients consecutively referred for acute coronary syndrome, including ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. Upon admission (T0), all patients underwent coronary angiography to assess the number of pathologic coronary vessels. Percutaneous transluminal coronary angioplasty (PTCA) was performed based on angiogram results if indicated. The sample was categorized into two groups: non-revascularized (no-PTCA) and revascularized (PTCA). Transthoracic echocardiograms to measure epicardial fat thickness were conducted at admission (T0) and after a 3-year follow-up (T1). RESULTS AND CONCLUSIONS: findings revealed a positive correlation between EAT thickness and the severity of coronary artery disease (CAD), with patients undergoing PTCA showing decreased EAT thickness after three years. Echocardiography demonstrated reliability in assessing EAT, offering potential for risk stratification. The study introduces a cut-off value of 0.65 cm as a diagnostic tool for cardiovascular risk. Incorporating EAT measurements into clinical practice may lead to more precise risk stratification and tailored treatment strategies, ultimately reducing the burden of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Romano et al. (2023) conducted an observational in Acute coronary syndrome (n=150). Percutaneous transluminal coronary angioplasty (PTCA) vs. Non-revascularized (no-PTCA) was evaluated on Epicardial fat thickness (EAT) at 3-year follow-up (p=<0.001). In patients with acute coronary syndrome, epicardial fat thickness significantly decreased three years after percutaneous transluminal coronary angioplasty compared to an increase in non-revascularized patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: